Senolytic Agent Improve the Benefit of Platelet-Rich Plasma and Losartan
Clinical trial NCT05025956 · UNKNOWN
Trial details
- NCT number
- NCT05025956
- Sponsor
- Steadman Philippon Research Institute
- Status
- UNKNOWN
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2021-10-24
- Primary completion
- 2024-10-31
- Enrollment
- 68
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.